MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction is a clinical trial[1].
Key Facts
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction is in the country of Spain[2].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's instance of is recorded as clinical trial[3].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's start time is recorded as +2017-07-01T00:00:00Z[4].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's end time is recorded as +2019-03-31T00:00:00Z[5].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's sponsor is recorded as Hospital Clinic of Barcelona[6].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's main subject is recorded as myocardial infarction[7].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's number of participants is recorded as {'unit': '1', 'amount': '+151'}[8].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's title is recorded as MAGnesium-based Bioresorbable Scaffold and Vasomotor Function in Patients With Acute ST Segment Elevation Myocardial Infarction[9].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's short name is recorded as MAGSTEMI[10].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's ClinicalTrials.gov ID is recorded as NCT03234348[12].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+90'}[13].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's clinical trial phase is recorded as phase II clinical trial[14].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's clinical trial phase is recorded as phase III clinical trial[15].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's research site is recorded as Hospital La Paz Institute for Health Research[16].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's research site is recorded as Hospital Universitario Ramón y Cajal[17].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's research subject recruitment status is recorded as completed[18].
- MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction's study type is recorded as interventional study[19].